Patents Assigned to iPierian, Inc.
-
Patent number: 10400018Abstract: Isolated tau peptides, and compositions comprising the peptides are disclosed. Further provided are antibodies specific for an isolated tau peptide. Methods of using the isolated tau peptide in diagnostic and treatment including using a pharmaceutical composition comprising the isolated tau peptide for stimulating an immune response in an individual to a tau peptide, and methods of using antibodies in detection, diagnosis, and treatment of disorders including a tauopathy are further provided.Type: GrantFiled: February 14, 2014Date of Patent: September 3, 2019Assignee: iPierian, Inc.Inventors: Irene Griswold-Prenner, Graham Parry, Tony SangYoung Byun
-
Publication number: 20190169275Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.Type: ApplicationFiled: July 16, 2018Publication date: June 6, 2019Applicant: iPierian, Inc.Inventors: Irene Griswold-Prenner, Nancy E. Stagliano, Vu Cao Dang
-
Patent number: 10040847Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.Type: GrantFiled: January 3, 2017Date of Patent: August 7, 2018Assignee: iPierian, Inc.Inventors: Irene Griswold-Prenner, Nancy E. Stagliano, Vu Cao Dang
-
Patent number: 9777058Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.Type: GrantFiled: August 11, 2016Date of Patent: October 3, 2017Assignee: iPierian, Inc.Inventors: Irene Griswold-Prenner, Nancy E. Stagliano, Vu Cao Dang
-
Patent number: 9567395Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.Type: GrantFiled: August 15, 2013Date of Patent: February 14, 2017Assignee: IPIERIAN, INC.Inventors: Irene Griswold-Prenner, Nancy E. Stagliano, Vu Cao Dang
-
Publication number: 20160289309Abstract: The present disclosure provides methods for treating a tauopathy (e.g., an acute tauopathy) in an individual by administering an anti-Tau antibody to the individual. Also provided are methods of treating traumatic brain injury and methods of treating stroke in an individual by administering an anti-Tau antibody to the individual.Type: ApplicationFiled: November 25, 2014Publication date: October 6, 2016Applicant: IPIERIAN, INC.Inventors: Irene GRISWOLD-PRENNER, Graham PARRY
-
Patent number: 9447180Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.Type: GrantFiled: May 6, 2015Date of Patent: September 20, 2016Assignee: iPierian, Inc.Inventors: Irene Griswold-Prenner, Nancy E. Stagliano, Vu Cao Dang
-
Patent number: 9051367Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.Type: GrantFiled: September 9, 2014Date of Patent: June 9, 2015Assignee: iPierian, Inc.Inventors: Irene Griswold-Prenner, Nancy E. Stagliano, Vu Cao Dang
-
Patent number: 8980271Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.Type: GrantFiled: May 19, 2014Date of Patent: March 17, 2015Assignee: Ipierian, Inc.Inventors: Irene Griswold-Prenner, Nancy E. Stagliano, Vu Cao Dang
-
Patent number: 8980270Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.Type: GrantFiled: January 14, 2014Date of Patent: March 17, 2015Assignee: iPierian, Inc.Inventors: Irene Griswold-Prenner, Nancy E. Stagliano, Vu Dang
-
Patent number: 8926974Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.Type: GrantFiled: November 27, 2013Date of Patent: January 6, 2015Assignee: iPierian, Inc.Inventors: Irene Griswold-Prenner, Nancy E. Stagliano, Vu Dang, Sami Hussain, Jessica Michelle Bright
-
Publication number: 20140294831Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.Type: ApplicationFiled: May 19, 2014Publication date: October 2, 2014Applicant: iPierian, Inc.Inventors: Irene GRISWOLD-PRENNER, Nancy E. STAGLIANO, Vu DANG
-
Publication number: 20140234214Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.Type: ApplicationFiled: January 14, 2014Publication date: August 21, 2014Applicant: iPierian, Inc.Inventors: Irene Griswold-Prenner, Nancy E. Stagliano, Vu Dang
-
Publication number: 20140099304Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.Type: ApplicationFiled: December 12, 2013Publication date: April 10, 2014Applicant: iPierian, Inc.Inventors: Irene Griswold-Prenner, Nancy E. Stagliano, Vu Dang
-
Publication number: 20140099303Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.Type: ApplicationFiled: December 12, 2013Publication date: April 10, 2014Applicant: iPierian, Inc.Inventors: Irene Griswold-Prenner, Nancy E. Stagliano, Vu Dang
-
Publication number: 20140086921Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.Type: ApplicationFiled: November 27, 2013Publication date: March 27, 2014Applicant: iPierian, Inc.Inventors: Irene Griswold-Prenner, Nancy E. Stagliano, Vu Dang, Sami Hussain, Jessica Michelle Bright
-
Publication number: 20110281281Abstract: Provided herein are methods for generating human induced pluripotent stem cells free from genomic integration of exogenous transgenes by transfecting into nucleated blood cells one or more DNA expression vectors (e.g., plasmid vectors) that do not contain a mammalian origin of replication, and encode and permit expression of one or more reprogramming factors (e.g., Oct4, Sox2, Klf4, and c-Myc). Also provided herein are the integration-free human induced pluripotent stem cells obtained by the methods described herein.Type: ApplicationFiled: May 12, 2010Publication date: November 17, 2011Applicant: iPierian, Inc.Inventor: Stefan Irion
-
Patent number: 8048675Abstract: Provided herein are methods for generating human induced pluripotent stem cells free from genomic integration of exogenous transgenes by transfecting into nucleated blood cells one or more DNA expression vectors (e.g., plasmid vectors) that do not contain a mammalian origin of replication, and encode and permit expression of one or more reprogramming factors (e.g., Oct4, Sox2, Klf4, and c-Myc). Also provided herein are the integration-free human induced pluripotent stem cells obtained by the methods described herein.Type: GrantFiled: May 12, 2010Date of Patent: November 1, 2011Assignee: iPierian, Inc.Inventor: Stefan Irion
-
Publication number: 20110020814Abstract: Described herein are methods and compositions for selection of pluripotent stem cells from a population of mammalian cells (e.g., human) undergoing a process that induces some cells within the population to become pluripotent.Type: ApplicationFiled: June 4, 2010Publication date: January 27, 2011Applicant: IPIERIAN, INC.Inventors: JOHN DIMOS, KENNETH J. SEIDENMAN
